Online citations, reference lists, and bibliographies.

Recent Advances In Optical Imaging Technologies For The Detection Of Bladder Cancer.

Putu Angga Risky Raharja, Agus Rizal A H Hamid, Chaidir Arif Mochtar, Rainy Umbas
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
White-light cystoscopy (WLC) is the diagnostic standard for the detection of bladder cancer (BC). However, the detection of small papillary and subtle flat carcinoma in situ lesions is not always possible with WLC. Several adjunctive optical imaging technologies have been developed to improve BC detection and resection. Photodynamic diagnosis, which requires the administering of a photoactive substance, has a higher detection rate than WLC for the detection of BC. Narrow-band imaging provides better visualization of tumors by contrast enhancement between normal mucosa and well-vascularized lesions. A technology called confocal laser endomicroscopy can be used to obtain detailed images of tissue structure. Optical coherence tomography is a high-resolution imaging process that enables noninvasive, real-time, and high-quality tissue images. Several other optical imaging technologies are also being developed to assist with the detection of BC. In this review, we provide an overview of the strengths and weaknesses of these imaging technologies for the detection of BC.
This paper references
10.2214/AJR.17.17798
DWI as an Imaging Biomarker for Bladder Cancer.
Soichiro Yoshida (2017)
10.1016/B978-0-12-809939-1.00014-X
Treatment for TaT1 Tumors
Seung Wook Lee (2018)
10.1016/j.ucl.2015.01.001
Advances in imaging technologies in the evaluation of high-grade bladder cancer.
Dimitar V Zlatev (2015)
10.1097/01.ju.0000100480.70769.0e
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Jörg Schmidbauer (2004)
10.18632/oncotarget.13054
Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis
Weiting Kang (2017)
10.1007/s00345-009-0387-z
Application of new technology in bladder cancer diagnosis and treatment
Alvin C. Goh (2009)
10.1007/s00345-011-0659-2
Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate
Evelyne C. C. Cauberg (2011)
10.1111/j.1464-410X.2009.09119.x
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variability.
Harry W. Herr (2010)
10.1089/PHO.2016.4217
Photodynamic Diagnosis and Narrow-Band Imaging in the Management of Bladder Cancer: A Review.
KutwinPiotr (2017)
10.1016/j.eururo.2009.07.042
Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
Jörg Schmidbauer (2009)
10.1016/j.urolonc.2011.02.009
Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder.
Guangfu Chen (2013)
10.1097/01.ju.0000181814.73466.14
Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Dmitry Daniltchenko (2005)
10.1371/journal.pone.0170819
A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
Yiquan Xiong (2017)
10.3892/OL.2015.3280
Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer.
Kohei Kobatake (2015)
10.1089/end.2005.19.570
Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography.
Michael J. Manyak (2005)
Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?
Stavros Gravas (2012)
10.1111/j.1464-410X.2008.07846.x
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
Harry W. Herr (2008)
10.1016/j.juro.2009.06.039
Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy.
Geoffrey A. Sonn (2009)
10.1016/S0302-2838(01)00026-4
Guidelines on bladder cancer.
W Oosterlinck (2002)
10.1109/TBME.2012.2191783
Surface Mosaics of the Bladder Reconstructed From Endoscopic Video for Automated Surveillance
Timothy D. Soper (2012)
10.5858/arpa.2011-0147-oa
Multiphoton microscopy in the evaluation of human bladder biopsies.
Manu Jain (2012)
10.1016/j.ajur.2016.05.001
Narrow band imaging for bladder cancer
Thomas Y. Hsueh (2016)
10.1093/jjco/hyv066
Urologic cancer in Indonesia.
Rainy Umbas (2015)
10.1016/S0022-5347(05)64661-7
Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Martin Kriegmair (2002)
10.1097/MOU.0000000000000370
Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
Esmee Iml Liem (2017)
10.1021/ac100448p
In vivo bladder cancer diagnosis by high-volume Raman spectroscopy.
Ronald O.P. Draga (2010)
10.1111/j.1464-410X.2009.08839.x
Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin.
Eleanor R. Ray (2010)
10.5173/ceju.2016.780
Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer
Anna Kołodziej (2016)
10.1016/j.juro.2012.03.127
New optical imaging technologies for bladder cancer: considerations and perspectives.
Jen‐Jane Liu (2012)
10.1001/jamasurg.2015.3121
Optical Biopsy of Bladder Cancer Using Crowd-Sourced Assessment.
Stephanie P Chen (2016)
10.1016/j.eururo.2009.04.038
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.
P U Malmström (2009)
10.1117/12.763353
Detection of early bladder carcinoma by fluorescence cystoscopy with Hexvix(R): improvement of the specificity by microcystoscopy
Blaise Lovisa (2008)
10.1007/s10147-014-0748-5
Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion
Yoshio Naya (2014)
10.1111/j.1464-410X.2008.07964.x
The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology.
Christopher S. D. Lee (2008)
10.1016/j.eururo.2009.02.033
A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications.
Evelyne C. C. Cauberg (2009)
10.1097/MOU.0000000000000093
New imaging techniques for nonmuscle invasive bladder cancer
Friedrich-Carl von Rundstedt (2014)
10.1177/1756287212454181
Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: a prospective comparison to the standard approach
Bogdan Florin Geavlete (2012)
10.1016/J.EURURO.2009.05.047
Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience
Guido Dalbagni (2010)
10.1126/scitranslmed.3009457
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody
Ying Pan (2014)
10.1080/21681805.2017.1295101
Clinical relevance of narrow-band imaging in flexible cystoscopy: the DaBlaCa-7 study
Ditte Drejer (2017)
10.1016/j.urology.2008.02.002
Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Alvin C. Goh (2007)
10.1089/end.2010.0055
Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.
Katsunori Tatsugami (2010)
10.1002/cncr.28905
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
10.1159/000083277
Fluorescence Cystoscopy in the Management of Bladder Cancer: A Help for the Urologist!
Patrice Jichlinski (2005)
10.1016/j.eururo.2009.09.037
Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy.
Ronald O.P. Draga (2010)
10.1038/srep10905
A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study
Zhangqun Ye (2015)
10.1089/end.2012.0549
Interobserver agreement of confocal laser endomicroscopy for bladder cancer.
Timothy Chang (2013)
10.5812/numonthly.33240
A Comparison of the Progression and Recurrence Risk Index in Non-Muscle-Invasive Bladder Tumors Detected by Narrow-Band Imaging Versus White Light Cystoscopy, Based on the EORTC Scoring System
Pejman Shadpour (2016)
10.1111/j.1464-410X.2010.09547.x
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy.
Harry W. Herr (2011)
10.1016/j.juro.2013.01.100
Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study.
Christof Schaefauer (2013)
10.1016/j.eururo.2007.01.064
Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
Maximilian Burger (2007)
10.1016/j.eururo.2016.03.053
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Proto
Seiji Prof Naito (2016)
10.1016/j.urology.2006.12.023
Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Stefan Denzinger (2007)
10.1016/j.urology.2008.02.062
Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
Bárbara Hermes (2008)
10.1111/j.1464-410X.2012.11500.x
Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.
Changjian Zheng (2012)
10.1002/jbio.201200105
Combined use of fluorescence cystoscopy and cross-polarization OCT for diagnosis of bladder cancer and correlation with immunohistochemical markers.
Natalia D Gladkova (2013)
10.1016/j.eururo.2012.01.018
A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.
Angelo Naselli (2012)
10.1097/01.ju.0000060782.52358.04
Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study.
Patrice Jichlinski (2003)
10.1016/J.UROLONC.2010.12.002
Narrow band imaging cystoscopy.
Harry W Herr (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar